Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Copine-2 is a member of the copine family, a group of evolutionarily conserved calcium-dependent phospholipid-binding proteins found in eukaryotes. Copine-2 contains two N-terminal type II C2 domains responsible for calcium binding and membrane association, as well as a C-terminal von Willebrand factor type A (VWA) domain involved in protein–protein interactions[1][3][6]. Copine-2 can act as a calcium sensor, mediating the association of proteins with intracellular and plasma membranes in response to increased calcium levels[1][4][6]. While it is the product of the CPNE2 gene in humans, Copine-2’s best-characterized molecular roles involve calcium-dependent phospholipid interactions and membrane targeting. It is widely expressed, including in the brain, where copine family proteins play roles in neural function, synaptic activity, and potentially in neural diseases[1]. Currently, Copine-2 is not considered a classical therapeutic target (such as a receptor, enzyme, or transporter), and there are no known drugs directly interacting with it. Its involvement in disease is suggested by analogy to other copines but is not well established for Copine-2 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copine-2 (CPNE2).